Welcome Dana Abramovitz to 7investing!
April 12, 2021
We are very excited to welcome Dana Abramovitz as our newest 7investing lead advisor!
Dana Abramovitz is a lead advisor for 7investing. She joins the team by way of South by Southwest, where she managed the Health & MedTech track of programming and was responsible for listening for the most important conversations happening around health care, identifying the those leading the conversations, and giving those thought leaders a platform from which to speak.
Dana’s interest in health spans all aspects of the industry – from fitness and wellness to hospital systems and policy and everywhere in between (she loves to geek out on personalized medicine and drug delivery and is happy to share her opinion on health equity and social determinants of health.) After her first year in the pharmacy program at Purdue University she changed her major to pharmaceutical sciences so she could go to graduate school to study biochemistry. She received her PhD in biochemistry and molecular biophysics from Columbia University and did her post-doc at The Scripps Research Institute. She left academia to work for Ingenuity Systems, which was acquired by QIAGEN, and started her own video game company whose product was acquired by UbiSoft. After a decade in industry she received her Masters in Management from Stanford University Graduate School of Business, where she focused on health care investment and new ventures. After business school and prior to working at South by Southwest, she worked at Strand Life Sciences, a genomics and personalized medicine company based in Bangalore.
Dana is currently loving how mRNA, which she studied in grad school, is in the limelight and can potentially be used to combat other diseases in the near future.
In addition to analyzing health care companies, Dana is a Bar Method studio owner and instructor and is on the founding team of the Texas Global Health Security Innovation Ecosystem. She lives in Houston.
Please help us welcome Dana to our 7investing team. And we can’t wait to share her first recommendation with our subscribers on May 1st!